These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

162 related items for PubMed ID: 2949163

  • 21. [Comparative study of various schedules of buflomedil treatment in peripheral arterial insufficiency of the lower limbs. Evaluation of its therapeutic efficacy].
    Paoletti V, Mammarella A, Alessandrini A, Barlattani M.
    Clin Ter; 1984 Jul 15; 110(1):29-36. PubMed ID: 6237843
    [No Abstract] [Full Text] [Related]

  • 22. Effects of buflomedil in a group of patients with chronic peripheral arterial diseases. Clinical and hemorheological evaluation.
    Mozzi E, Chiurazzi D, Spinola A, Annoni F, Germiniani R.
    J Int Med Res; 1985 Jul 15; 13(6):317-21. PubMed ID: 4076530
    [Abstract] [Full Text] [Related]

  • 23. [Treatment of circulatory insufficiency with buflomedil chlorhydrate in chronic hemodialysis patients].
    Montemurro NE, Damiano M.
    Clin Ter; 1986 Mar 31; 116(6):485-9. PubMed ID: 3720235
    [No Abstract] [Full Text] [Related]

  • 24. [Clinical evaluation of the activity of buflomedil in ischemic processes in the legs].
    Savagnone E, Sunseri V.
    Minerva Cardioangiol; 1985 Nov 31; 33(11):757-64. PubMed ID: 4088478
    [No Abstract] [Full Text] [Related]

  • 25. Effects of buflomedil hydrochloride in occlusive arterial disease of the lower limbs stage IV.
    Briguglio F, Briguglio E, Di Marco V, Swat M, Materia G, Intilisano A.
    J Int Med Res; 1986 Nov 31; 14(3):115-23. PubMed ID: 3721052
    [Abstract] [Full Text] [Related]

  • 26. [Acute affect of buflomedil hydrochloride (bufedil) on transcutaneously measured oxygen pressures in patients with peripheral arterial occlusive disease].
    Lemke R, Klaus D.
    Vasa; 1984 Nov 31; 13(2):171-4. PubMed ID: 6741240
    [No Abstract] [Full Text] [Related]

  • 27. [Effect of the vasoactive drug buflomedil in arterial occlusive disease].
    Racenberg J, Intaglietta M, Messmer K.
    Fortschr Med; 1982 Nov 04; 100(41):1926-30. PubMed ID: 7152426
    [Abstract] [Full Text] [Related]

  • 28. Effect of buflomedil chlorhydrate on local oxygen delivery in peripheral vascular disease.
    Mannarino E, Pasqualini L, Maragoni G, Orlandi U.
    Angiology; 1989 Jun 04; 40(6):559-62. PubMed ID: 2719340
    [Abstract] [Full Text] [Related]

  • 29. [Evaluation of the efficacy of medical treatment, especially anticoagulant treatment, in arteriopathies of the lower limbs. Apropos of 41 cases].
    Chérif T, Kallel N, Guediche M.
    Tunis Med; 1986 May 04; 64(5):475-80. PubMed ID: 3824555
    [No Abstract] [Full Text] [Related]

  • 30. [Epidemiologic study of peripheral obstructive arteriopathies: clinical effects of treatment with buflomedil chlorhydrate (Loftyl). Processing of data furnished by a polycenter study].
    Minerva Med; 1985 Oct 13; 76(39):1803-11. PubMed ID: 4047463
    [Abstract] [Full Text] [Related]

  • 31. [Ifenprodil tartrate in the treatment of occlusive arteriopathies of the lower limbs. Results of a prospective double-blind controlled multicenter trial].
    Natali J, Kieny R, Le Bas P, Benhamou M, Molkhou JM.
    Ann Cardiol Angeiol (Paris); 1989 Jun 13; 38(6):339-42. PubMed ID: 2667444
    [No Abstract] [Full Text] [Related]

  • 32. [Clinical experimentation with a new vasodilator: cinepazide maleate in arterial diseases of the lower limbs].
    Warembourg G, Carre A, Ginestet A, Lambert M.
    Lille Med; 1976 Dec 13; 21 Suppl 4():898-901. PubMed ID: 1018614
    [No Abstract] [Full Text] [Related]

  • 33. [Treatment with mesoglycan of chronic obliterative atherosclerotic arteriopathies of the legs. Hematochemical and flowmetric changes].
    di Giovanna VN.
    Clin Ter; 1988 Jun 30; 125(6):431-4. PubMed ID: 2973949
    [No Abstract] [Full Text] [Related]

  • 34. [Buflomedil chlorhydrate in the treatment of retinopathies].
    Spallone A, Porta E, Bertazzi E, Ridling P, Ortolina S, Fatigati G, Carlevaro G, Visentin E, Capilli G.
    Clin Ter; 1987 Apr 30; 121(2):125-8. PubMed ID: 2956000
    [No Abstract] [Full Text] [Related]

  • 35. [Buflomedil in the treatment of chronic peripheral arterial diseases. Case contribution].
    Visconti W, Grillo N.
    Minerva Med; 1985 May 12; 76(19-20):945-53. PubMed ID: 3158842
    [Abstract] [Full Text] [Related]

  • 36. [Vasodilators and arteriopathies of the lower extremities].
    Mazzola C.
    Soins; 1978 Nov 20; 23(22):35-6, 38. PubMed ID: 31689
    [No Abstract] [Full Text] [Related]

  • 37. [Bencyclane in stage II arterial occlusive disease. Results of a controlled study].
    Trübestein G, Trübestein R, Ludwig M.
    Fortschr Med; 1989 Dec 20; 107(36):781-4. PubMed ID: 2695437
    [Abstract] [Full Text] [Related]

  • 38. [Effect of buflomedil perfusion on peripheral tissue oxygenation during transluminal angioplasty in patients with advanced arteriopathy of the lower limbs].
    Joffre F, Meites G, Rousseau H, Staffin C, Allaert FA, Pelat P.
    Ann Radiol (Paris); 1994 Dec 20; 37(3):239-44. PubMed ID: 8092756
    [Abstract] [Full Text] [Related]

  • 39. [Use of buflomedil chlorhydrate in vertiginous patients. Vertigo].
    Pianura CM, Di Lillo ML, Galati F, Massatani M, Mignano M.
    Minerva Cardioangiol; 1985 Jun 20; 33(6):369-72. PubMed ID: 4047427
    [No Abstract] [Full Text] [Related]

  • 40. [Transcutaneous measures of oxygen partial pressure and capillaroscopic parameters as affected by naftidrofuryl in patients with obliterative arteriopathies, Fontaine stages II-IV].
    Ranft J, Heidrich H, Lammersen T.
    J Mal Vasc; 1987 Jun 20; 12(1):78-81. PubMed ID: 3559415
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.